Total Ischemic Time has Prognostic Implications on Short Term Outcome of Primary Percutaneous Coronary Intervention (pPCI)

Authors

  • Dr. Md. Golam Morshed

Keywords:

enzymes., Burns, hypertrophic scars, skin grafts, collagenase, recombinant., Total ischemic time, Primary PCI (pPCI), prognostic implications.

Abstract

Objectives: Primary percutaneous coronary intervention (pPCI) is being increasingly done as the treatment of acute ST elevation myocardial infarction (STEMI). Time until treatment is paramount in the management of STEMI. But the total ischemic time before pPCI how much influencing the outcome is a matter of interest. So we evaluated the influence of total ischemic time on myocardial reperfusion and short term clinical outcome in patients with STEMI treated with primary PCI.

Methods: This prospective observational study was conducted from August 2017 to July 2018 in the Department of Cardiology, National Institute of Cardiovascular Diseases (NICVD), Dhaka. Forty eight (48) acute STEMI patients were selected by purposive sampling based on inclusion and exclusion criteria dividing into two groups as short total ischemic time in whom pain to pPCI time was

References

B R Walker, N R Colledge, S H Ralston, I Penman (2014) Davidson's Principle and Practice of Medicine. 579-581.

CB Granger, WM Kenneth, WW Douglas (2006) Pexelizumab, an anti C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the complement inhibition in myocardial infarction treated with angioplasty (COMMA) trail. 108, 1184-1190.

MA Elliott (2012) ST elevation myocardial infarction: pathology, pathophysiology and clinical features. 1087-1109.

M Moscucci, KA Eagle (2006) 113(8), 1048-50.

N Beohar, CJ Davidson, G Weigold (2001) 88, 1103–7.

T Geisler, K Muller, A Karathanos (2014) Impact of antithrombotic treatment on short term outcomes after PCI of left main disease: a pooled analysis from REPLACE 2, ACUITY, and HORIZONS-AMI trails. 10(1), 97-104.

C Wilhelmsson, J A Vedin, D Elmfeldt (1975) Smoking and Myocardial Infarction. 1, 415-420.

L O Jensen, M Maeng, P Thayssen (2012) Influence of diabetes mellitus on clinical outcomes following primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. 109(5), 629-35.

S N Willich, J M Müller-Nordhorn, M Kulig (2001) Cardiac risk factors, medication, and recurrent clinical events after acute coronary disease: a prospective cohort study. 22(4), 307–313.

P S Yusuf, S Hawken, S Ounpuu (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. 364(9438), 937–952.

G De Luca, MT Dirksen, C Spaulding Impact of hypertension on clinical outcome in STEMI patients undergoing primary angioplasty with BMS or DES: insights from the DESERT cooperation. 175, 50-4.

J Fang, MH Alderman (2002) Dissociation of hospitalization and mortality trends for myocardial infarction in the United States from 1988 to 1997. 113, 208.

R K Krikorian, J L Vacke, G D Beauchamp (1995) Timing, mode, and predictors of death after direct angioplasty for acute myocardial infarction. 35, 192–196.

R S Hermanides, J P Ottervanger, J H Dambrink (2010) Incidence, predictors and prognostic importance of bleeding after primary PCI for ST-elevation myocardial infarction. 6, 106-11.

R H Mehta, K J Harjai, L Grines (2014) Sustained ventricular tachycardia or fibrillation in the cardiac catheterization laboratory among patients receiving primary percutaneous coronary intervention: incidence, predictors, and outcomes. 43, 1765–1772.

C L Grines, K F Browne, J Marco (1993) A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The primary angioplasty in myocardial infarction study group. 328, 673-9.

M L Fokkema, W G Wieringa, I C V D Horst, E Boersma, F Zijlstra, B J Smet (2011) Outcome after percutaneous coronary intervention Groningen. 108, 1536-1541.

E Falk, L Thuesen (2003) Pathology of coronary microembolisation and no reflow. 89, 983-985.

M Francone, C Bucciarelli-Ducci, I Carbone, E Canali, R Scardala, F A Calabrese Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and.

Downloads

Published

2024-05-28

How to Cite

Total Ischemic Time has Prognostic Implications on Short Term Outcome of Primary Percutaneous Coronary Intervention (pPCI). (2024). London Journal of Medical and Health Research, 24(5), 45-52. https://journalspress.uk/index.php/LJMHR/article/view/641